Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

cMET-dysregulated Advanced Solid Tumors × Rosuvastatin Calcium × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

cMET-dysregulated Advanced Solid Tumors 1 TP53 Y220C Mutation 1 Advanced Solid Tumor 1

Interventions

capmatinib 2 Rosuvastatin Calcium 1 Midazolam 1 Digoxin 1 Caffeine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02626234 2020-12-10

A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors

Novartis

Phase 1 Completed

Other solid neoplasm

cMET-dysregulated Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡